Cargando…
Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines
Canine mammary tumors (CMTs) are commonly observed in old and unspayed female dogs. Recently, dogs have been increasingly spaying at a young age to prevent mammary tumors. These CMTs require extensive local excision and exhibit a high probability of metastasis to the regional lymph nodes and lungs d...
Autores principales: | Yeom, Jiah, Cho, Yoonju, Ahn, Seoungyob, Jeung, Soyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10684731/ https://www.ncbi.nlm.nih.gov/pubmed/38033642 http://dx.doi.org/10.3389/fvets.2023.1279535 |
Ejemplares similares
-
In vitro anticancer effects of alpelisib against PIK3CA-mutated canine hemangiosarcoma cell lines
por: Maeda, Marika, et al.
Publicado: (2022) -
PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia
por: Arendt, Maja Louise, et al.
Publicado: (2023) -
Alpelisib: A Novel Therapy for Patients With PIK3CA-Mutated Metastatic Breast Cancer
por: Wilhoit, Tori, et al.
Publicado: (2020) -
Treatment of two infants with PIK3CA-related overgrowth spectrum by alpelisib
por: Morin, Gabriel, et al.
Publicado: (2022) -
Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives
por: Chang, Dwan-Ying, et al.
Publicado: (2021)